Pharmacokinetics, metabolism and bioavailability of the new anti- allergic drug BM 113 Part I: Pharmacokinetics and tissular distribution in Sprague-Dawley rats

Arzneimittel-Forschung/Drug Research

Volumn 49, Issue 6, 1999, Pages 504-508

  Duchêne, Patrick ^a   Tran, Gilles ^b   Ladure, Philippe ^b   Ollivier, Roland ^b   Buzas, André ^c   Merour, Jean Yves ^c   Houin, Georges ^d  

^a ADME BIOANALYSES   (France)

^b Laboratoires Meram   (France)

^c UNIVERSITÉ D'ORLÉANS   (France)

^d CHU RANGUEIL   (France)

Author keywords

1 (Benzhydryloxyethyl)piperidino 4 ethylacetate; Antiallergic drugs; BM 113, pharmacokinetics, rat, tissue distribution; CAS 115313 91 2; CAS 115313 90 1

Indexed keywords

1 (BENZHYDRYLOXYETHYL)PIPERIDINO 4 ETHYLACETATE; ANTIALLERGIC AGENT; UNCLASSIFIED DRUG;

ALLERGY; ANIMAL EXPERIMENT; ARTICLE; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; LIPOPHILICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0033036652     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300451     Document Type: Article

References (1)

1. Buzas, A., Merour, J. Y., Ollivier, R., EP 87401959, 18 pp. 02/09/87